Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2017

Aug 1, 2017

30597_dirs_2017-08-01_960a05c7-77f0-4165-9f27-d498e8a147b3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-07-28

Reporting Person: Elliott Jeffrey Thomas (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-28 Common Stock M 18750 $0.00 Acquired 19861 Direct
2017-07-31 Common Stock S 5846 $39.41 Disposed 14015 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-07-28 Restricted Stock Units $ M 18750 Disposed Common Stock (18750) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 472 Indirect

Footnotes

F1: Represents shares of common stock received upon vesting of a restricted stock unit award.

F2: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on July 28, 2017.

F3: Each restricted stock unit represents a contingent right to receive one share of common stock.

F4: Represents a restricted stock unit award granted on July 28, 2016 that partially vested on July 28, 2017. The restricted stock units vest in four equal annual installments beginning on July 28, 2017.